Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy

被引:0
|
作者
Mirelis, Jesus G. [1 ,2 ,3 ]
Sanchez-Gonzalez, Javier [1 ,4 ]
Zorio, Esther [5 ]
Ripoll-Vera, Tomas [6 ]
Salguero-Bodes, Rafael [7 ]
Filgueiras-Rama, David [1 ,2 ,8 ]
Gonzalez-Lopez, Esther [1 ,2 ,3 ]
Gallego-Delgado, Maria [1 ,2 ]
Fernandez-Jimenez, Rodrigo [1 ,2 ,9 ]
Jesus Soleto, Maria [6 ]
Nunez, Juana [6 ]
Pizarro, Gonzalo [1 ,2 ,10 ]
Sanz, Javier [9 ]
Fuster, Valentin [1 ,9 ]
Garcia-Pavia, Pablo [1 ,2 ]
Ibanez, Borja [1 ,2 ,11 ]
机构
[1] Inst Salud Carlos III, CNIC, Area Fisiopatol Miocardio, Madrid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
[3] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[4] Philips Healthcare, Dept Ciencia Clin, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Dept Cardiol, Valencia, Spain
[6] Hosp Son Llatzer & IdISPa, Dept Cardiol, Palma de Mallorca, Spain
[7] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Cardiol, New York, NY 10029 USA
[10] Univ Europea Madrid, Complejo Hosp Ruber Juan Bravo, Dept Cardiol, Madrid, Spain
[11] IIS Hosp Fundac Jimenez Diaz, Dept Cardiol, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2017年 / 70卷 / 11期
关键词
Hypertrophic cardiomyopathy; Computed tomography; Extracellular volume; Diffuse fibrosis; CARDIAC MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2011 ACCF/AHA GUIDELINE; SUDDEN-DEATH; TASK-FORCE; PROGNOSTIC VALUE; FIBROSIS; PREVALENCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.recesp.2017.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. Methods: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. Results: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 +/- 15.6 years. Mean ECV +/- standard deviation in the septal left ventricular wall and was 29.8% +/- 6.3% in cases (n = 24) vs 31.9% +/- 8.5% in controls (n = 54); P=.282. Mean ECV in the lateral wall was 24.5% +/- 6.8% in cases vs 28.2% +/- 7.4% in controls; P=.043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P=.056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. Conclusions: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients. (C) 2017 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [21] Malignant ventricular arrhythmias in alcoholic cardiomyopathy
    Guzzo-Merello, Gonzalo
    Dominguez, Fernando
    Gonzalez-Lopez, Esther
    Cobo-Marcos, Marta
    Gomez-Bueno, Manuel
    Fernandez-Lozano, Ignacio
    Millan, Isabel
    Segovia, Javier
    Alonso-Pulpon, Luis
    Garcia-Pavia, Pablo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 199 : 99 - 105
  • [22] Myocardial Denervation and Left Ventricular Volume Predict Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy
    Malhotra, Saurabh
    Singh, Vasvi
    Fallavollita, James A.
    Canty, John M.
    Webb, Jessica
    Razavi, Reza
    Martorell, Jordi
    Sinkus, Ralph
    JACC-CARDIOVASCULAR IMAGING, 2022, 15 (06) : 1164 - 1166
  • [23] Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy
    Adduci, Carmen
    Boldini, Francesca
    Palano, Francesca
    Musumeci, Beatrice
    De Lucia, Carmine
    Russo, Domitilla
    Volpe, Massimo
    Autore, Camillo
    Francia, Pietro
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (08) : 2093 - 2098
  • [24] ORAL AMIODARONE IN HIGH-RISK VENTRICULAR ARRHYTHMIAS
    TORUNCHA, A
    GARCIABARRETO, D
    GONZALEZGOMEZ, A
    LLERENA, L
    SELLEN, J
    RAMOSEMPERADOR, C
    CABRERAALONSO, C
    HERNANDEZCANERO, A
    COR ET VASA, 1982, 24 (05) : 354 - 364
  • [25] Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy
    D'Andrea, A
    Caso, P
    Severino, S
    di Uccio, FS
    Vigorito, F
    Ascione, L
    Scherillo, M
    Calabrò, R
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2005, 22 (07): : 571 - 578
  • [26] Myocardial Perfusion Abnormalities: A Potential Biomarker for Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Young Patients?
    Chevalier, Philippe
    Deliniere, Antoine
    Millat, Gilles
    Asatryan, Babken
    Janin, Alexandre
    Bessiere, Francis
    Boiteux, Clement
    Haddad, Christelle
    CIRCULATION, 2022, 146
  • [27] CIRCULATING MATRIX METALLOPROTEINASE-3 IS ASSOCIATED WITH VENTRICULAR ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
    Zachariah, Justin
    Colan, Steven D.
    Lang, Peter
    Triedman, John K.
    Alexander, Mark E.
    Walsh, Edward P.
    Berul, Charles I.
    Cecchin, Frank
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E454 - E454
  • [28] MALIGNANT VENTRICULAR ARRHYTHMIAS ARE ASSOCIATED WITH DILATED CARDIOMYOPATHY IN GREAT DANES.
    Stephenson, H.
    Fonfara, S.
    Lopez-Alvarez, J.
    Dukes-McEwan, J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (03) : 712 - 712
  • [29] Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias, and Cardiomyopathy Associated With Loperamide Abuse
    Vaughn, Patricia
    Solik, Michelle M. K.
    Bagga, Shiv
    Padanilam, Benzy J.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (10) : 1230 - 1233
  • [30] Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy
    Mulia, Eka Prasetya Budi
    Suwanto, Denny
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (02): : 121 - 122